InvestorsHub Logo
Followers 1322
Posts 247420
Boards Moderated 55
Alias Born 12/07/2009

Re: None

Tuesday, 11/14/2017 2:10:17 PM

Tuesday, November 14, 2017 2:10:17 PM

Post# of 18996
Cytta Corp selected CardioComm as its preferred provider to augment their existing M-Health/telemedicine and IoT remote patient monitoring solution due to CardioComm’s expertise in supplying ECG monitoring devices, connectivity solutions and ECG reviewing software that are cleared as Class II medical devices by the US FDA and Health Canada regulatory authorities. CardioComm’s software as a medical device (“SaaMD”) ECG solutions are capable of accepting raw ECG data from any Bluetooth enabled ECG devices to generate an accurate ECG trace rendered on a scaled grid, delivered with information that is specific to the individual the ECG was recorded from as well as those who reviewed and reported the ECG findings.

$CYCA


ALL comments are In My Own OPINION. Please Use Your Own DD for Stock Trading.